Presentation is loading. Please wait.

Presentation is loading. Please wait.

A new lipid formulation of low dose ibuprofen shows non-inferiority to high dose standard ibuprofen: the FLARE study (flaring arthralgia relief evaluation.

Similar presentations


Presentation on theme: "A new lipid formulation of low dose ibuprofen shows non-inferiority to high dose standard ibuprofen: the FLARE study (flaring arthralgia relief evaluation."— Presentation transcript:

1 A new lipid formulation of low dose ibuprofen shows non-inferiority to high dose standard ibuprofen: the FLARE study (flaring arthralgia relief evaluation in episodic flaring knee pain) – a randomised double-blind study  S.M.A. Bierma-Zeinstra, J. Brew, K. Stoner, R. Wilson, A. Kilbourn, P.G. Conaghan  Osteoarthritis and Cartilage  Volume 25, Issue 12, Pages (December 2017) DOI: /j.joca Copyright © 2017 The Authors Terms and Conditions

2 Fig. 1 CONSORT diagram. Osteoarthritis and Cartilage  , DOI: ( /j.joca ) Copyright © 2017 The Authors Terms and Conditions

3 Fig. 2 Effect of treatment on WOMAC pain subscale scores.
Osteoarthritis and Cartilage  , DOI: ( /j.joca ) Copyright © 2017 The Authors Terms and Conditions

4 Fig. 3 Change from baseline in self-reported symptoms (NRS evaluation). Osteoarthritis and Cartilage  , DOI: ( /j.joca ) Copyright © 2017 The Authors Terms and Conditions


Download ppt "A new lipid formulation of low dose ibuprofen shows non-inferiority to high dose standard ibuprofen: the FLARE study (flaring arthralgia relief evaluation."

Similar presentations


Ads by Google